Original paperMale breast cancer: Results of the treatments and prognostic factors in 397 cases
References (32)
- et al.
Male breast cancer
Surg Clin North Am
(1990) - et al.
Prognosis of breast cancer in males: an analysis of 170 cases
Eur J Cancer
(1994) - et al.
Carcinoma of the male breast: report of a series of 88 cases
Clin Radial
(1976) - et al.
Male breast carcinoma: a single centre report of clinical parameters
Clin Oncol
(1994) - et al.
Post-mastectomy megavoltage radiotherapy: the Oslo and Stockhohn trials
Eur J Cancer
(1992) Tamoxifen in the treatment of male breast carcinoma
Clin Radial
(1983)- et al.
Cancer of the male breast
World J Surg
(1983) - et al.
Male breast cancer
Clin Oncol
(1981) - et al.
Tumeurs du sein chez l'homme. Etude anatomo-clinique. 73 observations
Nouv Presse Med
(1982) - et al.
Cancer du sein chez l'homme: 106 observations
Presse Médicale
(1993)
Epidemiology of male breast cancer. A meta-analysis of published case-control studies and discussion of selected etiological factors
Int J Cancer
(1993)
Male breast cancer: a clinicopathologic study of 97 cases
Ann Surg
(1978)
The prognosis of breast cancer in males. A report of 335 cases
Cancer
(1993)
Male breast cancer. 5. Clinical manifestations in 257 cases in Denmark
Br J Cancer
(1973)
Male breast cancer: a 13 year review of 89 patients
J Clin Oncol
(1984)
Breast cancer in the male: a report of 138 cases
World J Surg
(1980)
Cited by (209)
Triple negative apocrine carcinoma of the breast in man: Case report
2024, Revista de Senologia y Patologia MamariaTrends in surgery and survival for T1-T2 male breast cancer: A study from the National Cancer Database
2023, American Journal of SurgeryBreast Conserving Surgery Compared With Mastectomy in Male Breast Cancer: A Brief Systematic Review
2020, Clinical Breast CancerCitation Excerpt :The postmastectomy radiotherapy rates ranged from 8% to 61%.9,10,12,16,17 Radiotherapy after BCS was discussed in 6 studies, with mixed findings.9-11,13,14,16,17 Of the 6 studies, 5 had evaluated the outcomes for radiotherapy with the BCS and mastectomy patients combined.
Negative Lymph Node Count and Lymph Node Ratio Are Associated With Survival in Male Breast Cancer
2018, Clinical Breast CancerHormone Receptor-Positive Breast Cancer Has a Worse Prognosis in Male Than in Female Patients
2017, Clinical Breast CancerCitation Excerpt :Thus, some MBCs, particularly early stage HR+ MBC might have worse clinical outcomes than FBCs with the same stage. Male breast carcinoma has been considered similar to FBC, and MBC and FBC are currently treated similarly.3,5-8 Previously, reports of shorter OS in MBC attributed the change to older patient age and more advanced stages of disease.12,30,31
Copyright © 1995 Published by Elsevier Ltd.